Abbott Laboratories Stock

Equities

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:02 2024-05-10 pm EDT 5-day change 1st Jan Change
104.7 USD +0.07% Intraday chart for Abbott Laboratories -1.10% -4.84%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2024 * 41.7B Sales 2025 * 44.75B Capitalization 182B
Net income 2024 * 5.96B Net income 2025 * 7.18B EV / Sales 2024 * 4.5 x
Net Debt 2024 * 5.47B Net cash position 2025 * 640M EV / Sales 2025 * 4.06 x
P/E ratio 2024 *
30.6 x
P/E ratio 2025 *
26.1 x
Employees 114,000
Yield 2024 *
2.07%
Yield 2025 *
2.21%
Free-Float 86.95%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.07%
1 week-1.10%
Current month-1.16%
1 month-5.78%
3 months-6.32%
6 months+11.46%
Current year-4.84%
More quotes
1 week
104.28
Extreme 104.28
106.60
1 month
104.25
Extreme 104.25
110.89
Current year
104.25
Extreme 104.25
121.64
1 year
89.67
Extreme 89.674
121.64
3 years
89.67
Extreme 89.674
142.60
5 years
61.61
Extreme 61.61
142.60
10 years
36.00
Extreme 36
142.60
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 14-12-31
Director of Finance/CFO 51 96-12-31
Chief Tech/Sci/R&D Officer - 89-12-31
Members of the board TitleAgeSince
Director/Board Member 69 17-02-15
Director/Board Member 63 17-06-28
Director/Board Member 65 11-12-08
More insiders
Date Price Change Volume
24-05-10 104.7 +0.07% 7,349,729
24-05-09 104.7 -0.26% 5,902,240
24-05-08 104.9 -1.16% 6,234,711
24-05-07 106.2 +0.50% 6,556,396
24-05-06 105.6 -0.25% 3,789,737

Delayed Quote Nyse, May 10, 2024 at 04:00 pm EDT

More quotes
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104.7 USD
Average target price
126.1 USD
Spread / Average Target
+20.43%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW